HARTFORD, Conn. — Connecticut has seen six influenza-related deaths since late September, according to a release Wednesday from the state Department of Public Health. These mark the first flu deaths of the 2026-27 respiratory virus season. DPH reports that all six flu…
The Connecticut Agricultural Experiment Station has received more than 5,000 tick submissions this year, already surpassing last year's total and well above its typical volume of about 3,000. Anyone can submit a tick for testing by bringing it to the station's testing…
BRIDGEPORT - Bridgeport High School students exploring careers in the health field got a close look at the work Oct. 19 during a field trip to WVU Medicine Wheeling Hospital. More than 60 students in freshman through senior grades levels attended. Heath science…
Firefighters found Jeffrey Wilson dead in his bed after responding to what they thought would be a routine emergency on Salvatore Court, East Haven police said. EAST HAVEN — Police in East Haven Tuesday identified the man found dead in a…
Wagner said opening the facility was a career highlight and that he was honored by its dedication, the report notes. Roger Mitty, president of Care New England Medical Group, said the goal is to bring most patients' ambulatory needs to…
Bristol Myers Squibb discloses results from it's Phase I Breakfree-2 trial of CAR-T therapy zola-cel for multiple sclerosis. The death occurred after Bristol Myers Squibb had already paused zola-cel studies following safety concerns at Novartis. Bristol Myers Squibb (BMS) has…
Although cigarette use has declined over the past decade, nicotine use remains a public health concern in Connecticut. About 26.9% of state residents ages 18 to 25 said they had vaped nicotine in the past 30 days, according to the CT Data Collaborative. About…
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. Tempus Expands Strategic Collaboration with…
Data reinforce the potential for immune reset with zolacabtagene autoleucel to address an underlying cause of multiple sclerosis In the Breakfree-2 study, the majority of adverse events were brief and reversible, generally consistent with previously reported zola-cel Phase 1 clinical trial…
Bristol-Myers Squibb (BMY) shares were down 2% after the company said Friday that a patient with highly active relapsing multiple sclerosis in the phase 1 breakfree-2 study evalua... Oops, something went wrong U.S. markets close in 1h 28m Bristol-Myers Squibb Shares Fall After Patient Dealth…
Care, hospitals and public health.